Perioperative Management of Pediatric Patients With Type 1 Diabetes Mellitus, Updated Recommendations for

Lizabeth D Martin1, Monica A Hoagland2, Erinn T Rhodes3

  • 1From the Department of Anesthesiology, University of Washington, Division of Pediatric Anesthesiology, Seattle Children's Hospital, Seattle, Washington.

Anesthesia and Analgesia
|November 6, 2019
PubMed

Insights

Pediatric patients with type 1 diabetes mellitus (T1D) require careful perioperative management, including fasting, insulin, and glucose monitoring. Guidelines address anesthesia for T1D children, focusing on insulin pumps and continuous glucose monitoring (CGM).

Area of Science:

  • Pediatric Anesthesiology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Type 1 Diabetes Mellitus (T1D) affects approximately 1 in 300 US children, necessitating specialized anesthetic care.
  • Perioperative management for pediatric T1D patients is complex, requiring attention to fasting, insulin, and glucose regulation.
  • Anesthetic decisions are influenced by glycemic control, insulin regimens, procedure type, and recovery expectations.

Framework:

  • A multi-institutional working group from the Society for Pediatric Anesthesia Quality and Safety Committee developed evidence-based recommendations.
  • The framework synthesizes current endocrinology and anesthesia literature for perioperative T1D care.
  • Best practice involves preoperative planning with patient endocrinologists.

Implementation:

  • Recommendations cover preoperative evaluation, intraoperative glucose monitoring, and insulin administration strategies.
  • Guidelines address fluid management and postoperative care for pediatric T1D patients.
  • Specific attention is given to managing insulin pumps and continuous glucose monitoring (CGM) devices.

Implications:

  • Standardized guidelines improve perioperative safety and outcomes for children with T1D.
  • Enhanced understanding of T1D perioperative needs supports anesthesiologists.
  • Integration of modern glucose monitoring technologies (CGM) is crucial for optimal patient management.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
819
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
626
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
527
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
533
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
243